Abstract Submission Guidelines

Abstract Submission Deadline: January 10, 2020

Participant Abstracts and Young Investigator Abstracts must be submitted on-line. Abstracts that are selected will be presented either orally or in a poster format. All abstracts selected will be formatted for the scientific program which will be distributed at the meeting.

Participant and IAC Young Investigator Abstract Competition Abstract Submission
 Important to Read!!

Conference attendees who are not participants in one of the invited senior investigators’ labs are eligible to submit abstracts. This includes abstract submissions for the Young Investigators Competition. Abstracts submitted before the deadline are reviewed, judged and scored by an international review committee. Based on overall scores, participant abstract submissions will be selected for either an oral or poster presentation. Please note, for abstracts that are selected for oral presentations the same person submitting the abstract must present the abstract.

Invited Senior Investigators:

  1. Iris Jaffe, MD, PhD Executive Director, Molecular Cardiology Research Institute, Tufts Medical Center Professor of Medicine, Tufts University School of Medicine

  2. Massimiliano Caprio, MD, PhD Full Professor of Endocrinology Head - Laboratory of Cardiovascular Endocrinology IRCCS San Raffaele Pisana 247, via di Val Cannuta - Rome, Italy

  3. Fumitoshi Satoh, MD, PhD Professor of Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine

IAC Young Investigator Abstract Competition and Award

The purpose of the IAC Young Investigator Award is to recognize young investigators with research in basic and/or clinical studies relevant to aldosterone and mineralocorticoid receptor biology.

Eligibility for the IAC Young Investigator Competition and Awards is confined to students and fellows with up to 5 years postdoctoral research experience, exclusive of clinical training, at the time the abstract is submitted. Previous finalists for the award may not participate. Each applicant must be nominated by their research mentor, limit one nominee per mentor.

Abstracts will be reviewed, judged and chosen by an international review committee. Abstracts will be judged on their scientific uniqueness, the quality of the hypothesis being tested and adherence to the primary goal of the award. Four abstracts will be chosen for the competition section of the scientific program and will be printed in the program book.

Travel awards will be presented to each of the chosen young investigator finalists. The first place winner will receive $1,000 USD. Each runner-up will receive $500 USD. Each participant will be presented with an award plaque. Each finalist will be responsible for securing their own hotel accommodations and travel.

It is expected that nominating mentors will attend the meeting with the competing Young Investigator.

Abstract Submission Guidelines

1.      Size. The entire abstract, including title, author(s), affiliation(s), city and state, text, graphics and/or tables, must fit on an 11 x 8.5" sheet of paper with 1" margins all around. 

2.      Margins: As a majority of word processor's have a default margin of 1.5 inches, it may be necessary for you to manually set your margin size. Please confirm 1" margins on your document prior to submitting.

3.      Font and Font Size: Arial 11 pt.

4.      Formatting: Use single spacing and normal headings throughout. Use left justification only. Do NOT use tab sets. Do NOT indent. Use hard returns only for paragraph spacing options. Do NOT place your abstract in a text box or apply a border of any type. Do NOT submit an abstract with the “Track Changes” feature turned on.

5.      Title. The title should be brief, clearly indicating the nature of the presentation. It should appear in title case (not all caps or lower case), bolded and italicized.

6.      Authors. List all author's names and institutions. Underline the presenting author’s name and institution only.

7.      Acknowledgements. Acknowledgements of grant support or funding may be provided at the end of the abstract.

8.      Body of Abstract. State the purpose of the study (preferably in one sentence). State methods used. Summarize results presented in sufficient detail to support the conclusions. State the conclusions reached. (It is not satisfactory to say, “The results will be discussed"). Include tables or images only if they are simple, neat, and fit within the allowed size limits. You may include both a table and an image but no more than one of each. Use standard abbreviations, e.g., RBC. Use kg., gm., mg., ml., L. (liter), mEQ.,M (meter), and % (percent). Place a special or unusual abbreviation in parentheses after the full word, the first time it appears. Use numerals to indicate numbers, except to begin sentences. Non-proprietary (generic) names of drugs should be used.

9.      Submission File. The preferred file format is MicroSoft Word. PDF files are not acceptable.

10.  Category Theme. Select an abstract category theme by clicking on the category of your choice. Only one category may be selected.

11.  Abstract Acceptance Notification. You will receive an abstract status notification via email no later than February 4th to inform you if your abstract has been accepted for an oral or poster presentation. The program planning committee cannot respond to any abstract status inquiries prior to this date. It is the responsibility of the presenting author to contact other authors about the status of the abstract.

12.  Presenting Author. A presenting author must be designated for each abstract. The presenting author is responsible for giving the oral and/or poster presentation, if the abstract is accepted. Presenting authors should speak and answer questions in English.

13.  Number of Submissions. You may submit as many abstracts as you wish. Each abstract requires an individual submission. DO NOT attach more than one abstract at a time to an email submission. The program planning committee will consider the total number of abstracts submitted by the same author when developing the program.

14.  Withdrawal Policy. Abstract submissions may be withdrawn anytime before and up to January 10, 2020.

15.  Changes to Submitted Abstracts. If you must make a change to your submitted abstracts, contact Roxanne Hall by email at rhall@mpi-evv.com. Absolutely no edits may be made after the abstract deadline date.

16.  Abstract Receipt Confirmation. Contact Roxanne Hall (rhall@mpi-evv.com) by email if you do not receive an e-mail or fax confirmation within 48 hours (2 days) of submitting your abstract. Lack of confirmation indicates that your abstract was not received.

17.  Deadline: Submit your abstract by January 10, 2020. Abstracts received after the deadline will not be considered for oral presentations or the Young Investigator Competition.


 Abstract Submission

  • Click here to register your abstract.

  • Complete the form and click on the submit button. (all fields are required)

  • Once your form is submitted you will immediately receive a confirmation on the screen.

  • Submit your abstract by attaching it to an email and typing in the Subject line either Participant or Young Investigator. Email to rhall@mpi-evv.com. In the body of the email message include the submitter's name and all contact information.

  • Young Investigator submissions must also include the nominating participant's name and contact information and the Young Investigator's name and contact information